The reason is that most brokers have valuations far above the current SP. The average broker target price is 50% above current SP. Given this, it would be reasonable if we didn't see many changes. Analysts will tend to see yesterday's presentation as confirming their current view, given that existing guidance was held to.
- Forums
- ASX - By Stock
- Brokers upgrades
APX
appen limited
Add to My Watchlist
3.54%
!
$1.17

The reason is that most brokers have valuations far above the...
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$1.17 |
Change
0.040(3.54%) |
Mkt cap ! $309.9M |
Open | High | Low | Value | Volume |
$1.15 | $1.22 | $1.15 | $15.24M | 12.79M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
9 | 44610 | $1.17 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.18 | 29898 | 4 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
9 | 44610 | 1.170 |
8 | 282075 | 1.165 |
10 | 140839 | 1.160 |
6 | 84000 | 1.155 |
8 | 127178 | 1.150 |
Price($) | Vol. | No. |
---|---|---|
1.175 | 29898 | 4 |
1.180 | 8544 | 1 |
1.185 | 99650 | 2 |
1.190 | 58392 | 3 |
1.195 | 8702 | 2 |
Last trade - 16.10pm 04/07/2025 (20 minute delay) ? |
Featured News
APX (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Dr Michael Thurn, CEO & MD
Dr Michael Thurn
CEO & MD
SPONSORED BY The Market Online